https://www.fiercebiotech.com/biotech/synaffix-rustles-another-adc-deal-allying-emergence-360m-biobuck-pact
Synaffix allies with Emergence in $360M biobuck ADC pact
Sep 6, 2022 - After inking deals with Genmab and MacroGenics this year alone, the Dutch biotech has landed a $360 million biobuck partnership with Emergence.
synaffixalliesemergenceadcpact
https://www.prnewswire.co.uk/news-releases/innovent-biologics-and-synaffix-expand-adc-collaboration-following-positive-preliminary-clinical-signal-from-ongoing-phase-1-study-302008012.html
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical...
/PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of...
innovent biologicssynaffixexpand